SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-026319
Filing Date
2021-05-11
Accepted
2021-05-11 08:51:18
Documents
62
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q apvo-10q_20210331.htm 10-Q 1529819
2 EX-10.1 apvo-ex101_98.htm EX-10.1 444732
3 EX-10.2 apvo-ex102_97.htm EX-10.2 1245737
4 EX-31.1 apvo-ex311_7.htm EX-31.1 20684
5 EX-31.2 apvo-ex312_8.htm EX-31.2 20858
6 EX-32.1 apvo-ex321_6.htm EX-32.1 10171
7 EX-32.2 apvo-ex322_9.htm EX-32.2 10278
8 GRAPHIC gwehug4nbidu000001.jpg GRAPHIC 16108
  Complete submission text file 0001564590-21-026319.txt   6926026

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT apvo-20210331.xml EX-101.INS 853467
10 XBRL TAXONOMY EXTENSION SCHEMA apvo-20210331.xsd EX-101.SCH 53232
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE apvo-20210331_cal.xml EX-101.CAL 36806
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE apvo-20210331_def.xml EX-101.DEF 158390
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE apvo-20210331_lab.xml EX-101.LAB 382299
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apvo-20210331_pre.xml EX-101.PRE 287279
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37746 | Film No.: 21909797
SIC: 2834 Pharmaceutical Preparations